SCHEMBL31639554

SCHEMBL31639554

CC(C)(C)OC(=O)N1CC=C(c2cnc(Cl)nc2)C(C)(C)C1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.45
POLB P06746 1/20 0.37
GRM5 P41594 1/20 0.36
CYP11B2 P19099 1/20 0.36
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PIK3R1 P27986 3/20 0.35
PIK3CA P42336 3/20 0.35
GPR119 Q8TDV5 6/20 0.34
USP30 Q70CQ3 2/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
HPGDS O60760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31639550 1.00 NR1H2 (0.45) NR1H2POLBGRM5CYP11B2CKS1B
SCHEMBL2160148 0.83 MEN1 (0.46) NR1H2POLBMEN1KMT2ASMN1; SMN2
SCHEMBL30487317 0.82 USP30 (0.44) NR1H2GRM5MEN1KMT2AMAPT
SCHEMBL2261033 0.78 NR1H2 (0.41) NR1H2GRM5CYP11B2MAPTPIK3R1
SCHEMBL31639966 0.78 CYP11B2 (0.42) NR1H2POLBGRM5CYP11B2CKS1B
SCHEMBL13275649 0.76 CYP11B2 (0.54) GRM5CYP11B2GPR119
SCHEMBL30872427 0.74 NR1H2 (0.43) NR1H2GRM5CYP11B2MEN1KMT2A
SCHEMBL30872426 0.74 NR1H2 (0.43) NR1H2GRM5CYP11B2MEN1KMT2A
SCHEMBL12217740 0.74 NR1H2 (0.48) NR1H2GRM5MEN1KMT2AMAPT
SCHEMBL17304324 0.74 NR1H2 (0.48) NR1H2GRM5MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 WO disclosed